Stress Management Industry: Global Trends

February 2020 | 134 pages | ID: S7C1FF3DFC39EN
BCC Research

Abstracts

REPORT SCOPE:

The report offers an exhaustive description and evaluation of the global stress management market. It provides in-depth qualitative and quantitative insights into the report, which aligns with the goals and objectives of our intended customers. The projections are verified through intensive primary and secondary research. The report will enable clients to obtain investment in the stress management industry on the basis of the current business scenario, trends and futuristic development in the segments. Keeping in mind the client’s needs, the report provides expert insights into the global stress management industry, its services and market trends. The market is forecasted through a bottom-up approach, which includes evaluation of the market through revenues generated by the key vendors of the market. It consists of market statistics that are unveiled by affirmed private publishers and various public organizations. The data encompasses the vogue and the newest industry players along with their pre-eminent company profiles. The information is thoroughly examined through extensive primary and secondary research carried by the research analysts.

The global stress management market has been segmented on the basis of mode of treatment, end user and age group. Geographically, the market has been divided into North America, Europe, Asia-Pacific (APAC) and the Rest of the World (RoW). A country-specific breakdown of the market is also included in the report. The study covers the global stress management market irrespective of the included countries. Countries were included mainly on the basis of total revenue generated. Major countries included in the report are the U.S., Canada, Germany, the U.K., Spain, Italy, France, China, Japan, South Korea and India. Sales data for the global and regional markets were corroborated for the present and forecasted values based on statistical analysis.

Estimated values used are based on market players’ total revenues and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation. Annual reports and forward-looking statement of stress management market players, annual sales of market players and average cost of software and services are considered for market estimations. A large number of stress management market players and potential startups are profiled in the report for a better understanding of the market.

The report on the stress management market provides a market overview, assesses modes of treatment, provides an end-user analysis, and analyzes the stress management market by mode of treatment, age group and end user. The major companies that were profiled in the report includes a detailed introduction, product portfolios and recent developments. The report also includes regulatory aspects, current and developing technologies, market projections, and market shares.

REPORT INCLUDES:

• 52 tables
• Detailed study and industry analysis of the global stress management market
• Analyses of the global market trends with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024
• A broad range of psychotherapies and techniques that are aimed at controlling the level of stress in individuals, primarily chronic stress along with several drugs and devices, available in the market for the treatment of stress
• Data corresponding to number of cases of work-related stress, depression or anxiety; as well as the prevalence and incidence rates
• Elaboration on the role of regulatory protocols, current and developing technologies, and other macroeconomic factors shaping the stress management marketplace
• Profile description of market leading companies, their product portfolios and recent developments, including Abbott Laboratories Inc., Eli Lilly and Co., GlaxoSmithKline PLC, Lupin Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc. and Takeda Pharmaceutical Co., Ltd.

Contents

CHAPTER 1 INTRODUCTION

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND

Market Trends
Antidepressant Demand Slows
Europe Dominates the Global Stress Management Market
Government Awareness Campaigns for Mental Health
Emerging Focus on Transcranial Magnetic Stimulation for Depression
Introduction of New Apps for Stress Management
Potential Growth of Off-Label Stress Reducers Such as ASMR
Market Dynamics
Factors Driving the Growth of the Market
Restraints

CHAPTER 4 MARKET BREAKDOWN BY TREATMENT TYPE

Drugs and Medications
Antidepressant Drugs
Atypical Antipsychotics
Beta-Blockers
Others (Benzodiazepines)
Therapies and Devices
Deep Brain Stimulation
Transcranial Magnetic Stimulation
Vagus Nerve Stimulation
Wearable Devices and Apps
ASMR (Autonomous Sensory Meridian Response)

CHAPTER 5 MARKET BREAKDOWN BY END USER

Hospitals
Ambulatory Surgical Centers
Others

CHAPTER 6 MARKET BREAKDOWN BY AGE GROUP

Children
Adults
Elderly

CHAPTER 7 MARKET BREAKDOWN BY REGION

North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Brazil
Mexico
South Africa

CHAPTER 8 PATENT REVIEW/NEW DEVELOPMENTS

CHAPTER 9 ANALYSIS OF MARKET OPPORTUNITIES

Increasing Adoption of Wearables and Smart Devices for Stress Relief
Significant FDA Approvals for Neurological Therapies
Recent FDA Approvals
Key Suppliers and Manufacturers
Eli Lilly and Co.
Otsuka Holding Co., Ltd.
H. Lundbeck A/S
Johnson & Johnson Services Inc.
AstraZeneca PLC
Strategies
Product Launches and Approvals
Collaborations and Partnerships
Geographical Expansion

CHAPTER 10 COMPANY PROFILES

ABBOTT LABORATORIES INC.
ALKERMES PLC
ALLERGAN PLC
APPLE INC.
ASTRAZENECA PLC
AZUMIO INC.
BAUSCH HEALTH COMPANIES INC.
BEIJING PINS MEDICAL CO., LTD.
BIOCONTROL MEDICAL LTD.
BRAINSWAY LTD.
BRISTOL-MYERS SQUIBB CO.
CAEDEN INC.
DARTA SYSTEMS
DEVON MEDICAL PRODUCTS INC.
ELECTROMEDICAL PRODUCTS INTERNATIONAL INC.
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE AG
FACEMETRICS LTD.
FISHER WALLACE LABORATORIES INC.
FITBIT INC.
GARMIN LTD.
GLAXOSMITHKLINE PLC
H. LUNDBECK A/S
HEADSPACE INC.
IBREVE LTD.
INTERAXON INC.
JOHNSON & JOHNSON SERVICES INC.
LIEF THERAPEUTICS
LIVANOVA PLC
LUPIN LTD.
MAG & MORE GMBH
MAGVENTURE INC.
MERCK & CO. INC.
MOOD TRACKER WEB MEDIA LLC
MYLAN N.V.
NEURONETICS INC.
NEUROSIGMA INC.
NEUVANA LLC
OTSUKA PHARMACEUTICAL CO., LTD.
PFIZER INC.
SAMSUNG ELECTRONICS CO., LTD.
SANVELLO HEALTH INC.
SPIRE INC.
TAKEDA PHARMACEUTICAL CO., LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
THYNC GLOBAL INC.
TINGLES INC.
WALDEN MEDICAL NEURO DIGITAL THERAPIES LLC

List Of Tables

LIST OF TABLES

Summary Table: Global Market for Stress Management Treatments, by Type, Through 2024
Table 1: Source of Stress Related to Specific Job Type
Table 2: Most Common SSRIs and Their Side Effects
Table 3: Global Market for Stress Management Treatments, by Type, Through 2024
Table 4: Global Market for Stress Management Treatments, by Drug Type, Through 2024
Table 5: Major Drug Classes Used in the Treatment of Stress-Associated Disorders
Table 6: Global Market for Drugs and Medications Used for Stress Management, by Region, Through 2024
Table 7: FDA Approved Antidepressants
Table 8: Details of Atypical Antipsychotic Drugs
Table 9: Global Market for Therapies and Devices Used in Stress Management, by Type, Through 2024
Table 10: Global Market for Therapies and Devices Used in Stress Management, by Region, Through 2024
Table 11: Wearable Devices and Apps Used for Stress Management
Table 12: Global Market for Stress Management Treatments, by End User, Through 2024
Table 13: Common Stress Management Services Offered in Hospitals
Table 14: Global Market for Stress Management Treatments in Hospitals and Clinics, by Region, Through 2024
Table 15: Global Market for Stress Management Treatments in Ambulatory Surgical Centers, by Region, Through 2024
Table 16: Global Market for Stress Management Treatments in Other End Uses, by Region, Through 2024
Table 17: Global Market for Stress Management Treatments, by Age Group, Through 2024
Table 18: Global Market for Stress Management Treatments for Children, by Region, Through 2024
Table 19: Major Causes of Stress Among Adults in the U.S.
Table 20: Global Market for Stress Management Treatments for Adults, by Region, Through 2024
Table 21: Global Market for Stress Management Treatments for the Elderly, by Region, Through 2024
Table 22: Global Market for Stress Management Treatments, by Region, Through 2024
Table 23: North American Market for Stress Management Treatments, by Type, Through 2024
Table 24: North American Market for Stress Management Treatments, by End User, Through 2024
Table 25: North American Market for Stress Management Treatments, by Age Group, Through 2024
Table 26: North American Market for Stress Management Treatments, by Country, Through 2024
Table 27: Canada's Mental Health Resources, 2017
Table 28: European Market for Stress Management Treatments, by Type, Through 2024
Table 29: European Market for Stress Management Treatments, by End User, Through 2024
Table 30: European Market for Stress Management Treatments, by Age Group, Through 2024
Table 31: European Market for Stress Management Treatments, by Country, Through 2024
Table 32: Germany's Mental Health Resources, 2017
Table 33: France's Mental Health Resources, 2017
Table 34: Italy's Mental Health Resources, 2017
Table 35: Spain's Mental Health Resources, 2017
Table 36: Asia-Pacific Market for Stress Management Treatments, by Type, Through 2024
Table 37: Asia-Pacific Market for Stress Management Treatments, by End User, Through 2024
Table 38: Asia-Pacific Market for Stress Management Treatments, by Age Group, Through 2024
Table 39: Asia-Pacific Market for Stress Management Treatments, by Country, Through 2024
Table 40: China's Mental Health Resources, 2017
Table 41: India's Mental Health Resources, 2017
Table 42: Rest of the World Market for Stress Management Treatments, by Type, Through 2024
Table 43: Rest of the World Market for Stress Management Treatments, by End User, Through 2024
Table 44: Rest of the World Market for Stress Management Treatments, by Age Group, Through 2024
Table 45: Patents on Stress Management Treatments, by Category in Different Countries, January 2016-August 2019
Table 46: Distribution of Major Patents on Stress Management Treatments, by Assignee, January 2016-December 2019
Table 47: Total Patents Analyzed for Stress Management Treatments, January 2016-December 2019
Table 48: Eli Lilly and Co.: Product Sales, by Country/Region, 2018
Table 49: Otsuka Pharmaceutical's Clinical Trials on Stress Management Treatments
Table 50: H. Lundbeck: Product Sales, 2017 and 2018
Table 51: Johnson & Johnson: Revenue Generated from Drugs Used in the Treatment of Depression, 2017 and 2018

List Of Figures

LIST OF FIGURES

Summary Figure: Global Market for Stress Management Treatments, by Type, 2018-2024
Figure 1: Breakdown of Mental Health-Related Insurance Claims, 2012-2017
Figure 2: Share of Claims Tied to Generalized Anxiety Disorder Among Young People, 2014-2017
Figure 3: Global Distribution of Diseases Causing Loss of Work Output, by Disease Type, 2018
Figure 4: Global Incidence of Major Depressive Disorder, by Region, 2015-2017
Figure 5: Behavioral Changes in Children: Depression and Anxiety, by Age Group, 2015
Figure 6: Incidence of Anxiety Disorders in North America, 2013-2017
Figure 7: Prevalence of Depressive Disorder in the U.S., 2013-2017
Figure 8: Number of Clinical Studies Based on Trauma, by Type, 1988-2018
Figure 9: Prevalence of Depressive Disorder in Canada, 2013-2017
Figure 10: Regional European Shares of Populations with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 11: Percentage of U.K.'s Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 12: Percentage of Germany's Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 13: Percentage of France's Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 14: Percentage of Italy's Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 15: Percentage of Spain's Population with Behavioral Health Disorders, by Type of Disorder, 2017
Figure 16: Percentage of Asia-Pacific's Population with Depression, by Country, 2017
Figure 17: Percentage of China's Population with Behavioral Health Disorders, by Type of Disorder, 2015-2017
Figure 18: Percentage of India's Population with Behavioral Health Disorders, by Type of Disorder, 2015-2017
Figure 19: Percentage of Japan's Population with Behavioral Disorders, by Type of Disorder, 2017
Figure 20: Percentage of Australia's Population with Behavioral Disorders, by Type of Disorder, 2017
Figure 21: Prevalence of Major Stress Disorders in Latin America, by Type of Disorder, 2015-2017
Figure 22: Prevalence of Major Stress Disorders in Brazil, by Type of Disorder, 2015-2017
Figure 23: Prevalence of Stress Disorders in Mexico, by Type of Disorder, 2015-2017
Figure 24: Prevalence of Major Stress Disorders in South Africa, by Type of Disorder, 2015-2017